Skip to search formSkip to main contentSkip to account menu

TAK-652

Known as: TAK 652 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

CCR5 Receptor AntagonistsImidazoles

Narrower (2)

TBR 652cenicriviroc

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
TAK-652, a Novel CCR5 Inhibitor, has Favourable Drug Interactions with other Antiretrovirals in Vitro
bioavailable CCR5 antagonist with potent in vitro anti-HIV-1 activity [1]. As with other classes of antiretroviral drug… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)